Tiziana Life Sciences Ltd
TLSA
Market Cap$167.09M
Close$
$0.01
99.2% downside
Current Fair Value
99.2% downsideOvervalued by 99.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $167.09 Million |
|---|---|
| Enterprise Value | $168.41 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.17 |
| Beta | 0.11 |
| Outstanding Shares | 100,589,070 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.13 |
|---|---|
| PEG | 4.13 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -4.32 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Tiziana Life Sciences Plc
CEO: Shailubhai Kunwar